Question

Difficulty: MediumNormal Pregnancy and Prenatal Care

An obstetrician is reviewing the standard prenatal care schedule with a patient who has just established care at 8 weeks gestation. The patient, who is pregnant with her first child, has an unremarkable medical history and is currently asymptomatic. To properly educate the patient on what to expect throughout her uncomplicated singleton pregnancy, the physician outlines the timeline for standard maternal and fetal assessments. Arrange the following routine prenatal interventions in the correct chronological sequence from the earliest gestational age to the latest.

  1. 1Baseline assessment of maternal blood type, Rh(D) status, and syphilis serology
  2. 2Fetal aneuploidy screening via nuchal translucency ultrasound and maternal serum markers
  3. 3Comprehensive fetal anatomy survey via transabdominal ultrasound
  4. 4Screening for gestational diabetes mellitus with a 1-hour, 50-g oral glucose challenge test
  5. 5Rectovaginal swab for Group B Streptococcus colonization

Answer

The correct chronological sequence is: Baseline assessment of maternal labs, followed by Fetal aneuploidy screening (nuchal translucency), then Comprehensive fetal anatomy survey, followed by Screening for gestational diabetes, and finally Rectovaginal swab for Group B Streptococcus.
The correct chronological sequence reflects the standard prenatal care timeline. Baseline labs (blood type, syphilis) are drawn at the initial visit. Aneuploidy screening utilizing nuchal translucency must be strictly timed between 11 and 13 weeks 6 days. The fetal anatomy scan is best performed between 18 and 22 weeks. Gestational diabetes screening occurs at 24-28 weeks to coincide with peak placental lactogen secretion. Finally, Group B Streptococcus screening is performed at 36-38 weeks to accurately reflect colonization status just prior to delivery.

Step-by-Step Solution

1
Identify the standard gestational age range for the baseline prenatal laboratory panel.
Typically performed at the initial obstetric visit (6-10 weeks).
Early detection of maternal blood type, Rh status, and infectious diseases allows for timely interventions before fetal harm can occur.
2
Determine the precise timing window for early aneuploidy screening.
Performed between 11 weeks and 13 weeks 6 days.
Nuchal translucency measurements and specific maternal serum markers (e.g., PAPP-A) are clinically validated only during this narrow early gestational window.
3
Identify the standard timing for the comprehensive fetal anatomy ultrasound.
Performed between 18 and 22 weeks.
At this mid-pregnancy stage, fetal structures are large enough to be adequately visualized, avoiding the third trimester when crowding and relatively lower amniotic fluid make imaging more difficult.
4
Determine the optimal gestational age for universal gestational diabetes screening.
Performed between 24 and 28 weeks.
Placental secretion of diabetogenic hormones, such as human placental lactogen, peaks in the late second and early third trimesters, making this the ideal time to detect insulin resistance.
5
Identify the timing for Group B Streptococcus (GBS) screening.
Performed between 36 and 38 weeks.
Because GBS colonization can be transient, screening late in the third trimester provides the most accurate prediction of colonization status at the time of labor, thereby guiding appropriate intrapartum antibiotic prophylaxis.

Key Concept

Routine prenatal care follows a strict, evidence-based timeline optimized for fetal development stages and changing maternal physiology: initial labs (6-10 weeks), early aneuploidy screening (11-14 weeks), anatomy ultrasound (18-22 weeks), GDM screening (24-28 weeks), and GBS screening (36-38 weeks).
Rate this question